Azzi A, Boscoboinik D, Clément S, Ozer N, Ricciarelli R, Stocker A
Institut für Biochemie und Molekularbiologie, Universität Bern, Switzerland.
Diabetes Res Clin Pract. 1999 Sep;45(2-3):191-8. doi: 10.1016/s0168-8227(99)00049-2.
Oxidant stress is associated with diminution of antioxidant molecules, such as alpha-tocopherol. Alpha-tocopherol specifically decreases, in a concentration dependent way, the proliferation of vascular smooth muscle cells. At the same concentrations (10-50 microM) it induces inhibition of protein kinase C (PKC) activity. The latter event is not due to a decrease in PKC level or to alpha-tocopherol binding to PKC, but it results from increase of protein phosphatase 2A1 activity. In vitro data, as well as at a cellular level, demonstrates that protein phosphatase 2A1 is activated, in its trimeric structure--but not as a dimer by alpha-tocopherol. This activation is followed by PKC-alpha dephosphorylation. The activation of protein phosphatase 2A1 and deactivation of PKC-alpha affect the AP1 transcription factor, resulting in a change in the composition and the binding of this factor to DNA. By transfecting smooth muscle cell with a construct containing three TRE (TPA responsive elements), the promoter thymidine kinase and the reporter gene chloramphenicol-acetyl-transferase a modulation of gene expression by alpha-tocopherol is observed. Beta-tocopherol does not cause any of the responses observed with alpha-tocopherol and R,R,R-alpha-tocopherol is twice as potent as all-rac-alpha-tocopherol. When added together, beta-tocopherol prevents the effects of alpha-tocopherol indicating that the mechanism involved is not related to the radical-scavenging properties of these two molecules, which are essentially equal. By differential display analysis it has been found that several genes of smooth muscle cells are differentially transcribed in the presence of alpha-tocopherol but not beta-tocopherol. In particular, the gene of alpha-tropomyosin shows a transient enhancement of transcription as a function of the cell cycle time. Alpha-tropomyosin translation is also increased by alpha-tocopherol and not by beta-tocopherol. Because no changes of mRNA stability can be observed in the presence of alpha-tocopherol, the data supports the conclusion of a transcriptional control exerted by alpha-tocopherol on alpha-tropomyosin. Generally, the data strongly suggests the existence of a ligand/receptor type of mechanism at the basis of alpha-tocopherol action. It is concluded that an oxidative stress-induced diminution of alpha-tocopherol in smooth muscle cell activates a reaction cascade leading to changes in gene expression and increase in cell proliferation by a non-antioxidant mechanism.
氧化应激与抗氧化分子(如α-生育酚)的减少有关。α-生育酚以浓度依赖性方式特异性降低血管平滑肌细胞的增殖。在相同浓度(10 - 50 microM)下,它会诱导蛋白激酶C(PKC)活性的抑制。后一事件并非由于PKC水平的降低或α-生育酚与PKC的结合,而是由于蛋白磷酸酶2A1活性的增加。体外数据以及细胞水平的数据表明,蛋白磷酸酶2A1在其三聚体结构中被α-生育酚激活,而不是以二聚体形式被激活。这种激活随后导致PKC-α去磷酸化。蛋白磷酸酶2A1的激活和PKC-α的失活影响AP1转录因子,导致该因子的组成及其与DNA的结合发生变化。通过用含有三个TRE(佛波醇酯反应元件)、胸苷激酶启动子和报告基因氯霉素乙酰转移酶的构建体转染平滑肌细胞,观察到α-生育酚对基因表达的调节作用。β-生育酚不会引起α-生育酚所观察到的任何反应,并且R,R,R-α-生育酚的效力是消旋-α-生育酚的两倍。当一起添加时,β-生育酚会阻止α-生育酚的作用,这表明所涉及的机制与这两种分子基本相同的自由基清除特性无关。通过差异显示分析发现,在存在α-生育酚但不存在β-生育酚的情况下,平滑肌细胞的几个基因转录存在差异。特别是,α-原肌球蛋白基因的转录随着细胞周期时间的变化而短暂增强。α-生育酚也会增加α-原肌球蛋白的翻译,而β-生育酚则不会。由于在存在α-生育酚的情况下未观察到mRNA稳定性的变化,这些数据支持α-生育酚对α-原肌球蛋白进行转录控制的结论。总体而言,数据强烈表明在α-生育酚作用的基础上存在配体/受体类型的机制。得出的结论是,氧化应激诱导的平滑肌细胞中α-生育酚的减少激活了一个反应级联,通过非抗氧化机制导致基因表达变化和细胞增殖增加。